Catalyst Pharmaceuticals SG&A Expense (Quarterly) Insights

Catalyst Pharmaceuticals Inc (CPRX)

14.75 -0.37 (-2.45%) USD | NASDAQ | Apr 25, 10:22

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2006. Upgrade now.

Date	Value
December 31, 2023	42.04M
September 30, 2023	33.56M
June 30, 2023	28.40M
March 31, 2023	29.72M
December 31, 2022	14.09M
September 30, 2022	13.65M
June 30, 2022	12.92M
March 31, 2022	16.43M
December 31, 2021	13.23M
September 30, 2021	12.15M
June 30, 2021	11.53M
March 31, 2021	12.72M
December 31, 2020	13.35M
September 30, 2020	9.985M
June 30, 2020	10.83M
March 31, 2020	10.06M
December 31, 2019	11.41M
September 30, 2019	8.068M
June 30, 2019	8.988M
March 31, 2019	8.416M
December 31, 2018	6.926M
September 30, 2018	3.644M
June 30, 2018	2.631M
March 31, 2018	2.674M
December 31, 2017	2.107M

Date	Value
September 30, 2017	1.602M
June 30, 2017	1.730M
March 31, 2017	1.866M
December 31, 2016	1.494M
September 30, 2016	1.42M
June 30, 2016	2.306M
March 31, 2016	2.691M
December 31, 2015	2.360M
September 30, 2015	1.975M
June 30, 2015	2.320M
March 31, 2015	1.942M
December 31, 2014	1.600M
September 30, 2014	1.223M
June 30, 2014	0.8912M
March 31, 2014	0.7597M
December 31, 2013	0.6388M
September 30, 2013	0.4414M
June 30, 2013	0.5215M
March 31, 2013	0.6131M
December 31, 2012	0.7607M
September 30, 2012	0.6289M
June 30, 2012	0.5346M
March 31, 2012	0.6374M
December 31, 2011	1.074M
September 30, 2011	0.5169M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

8.068M

Minimum

Sep 2019

42.04M

Maximum

Dec 2023

16.48M

Average

12.92M

Median

Jun 2022

SG&A Expense (Quarterly) Benchmarks